Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors — Stella

Home/Head and Neck Tumor/99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

View on ClinicalTrials.gov

Recruiting

Back to Head and Neck Tumor trials

99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors

Trial locations(1 site)

China

Nanjing First Hospital, Nanjing, Jiangsu

Key details

Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment target

~20 participants

Started

June 2024

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 75 Years

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.